Mergin 0.125mg Tablet
By Mergin
Rx
10 Tablet in a Strip

Composition
Methylergometrine(0.125mg)

Manufacturer - Shrinivas Gujarat Laboratories Pvt Ltd
604, Corporate House, Opp. Torrent House, Nr. Dinesh Hall, Ashram Road, Ahmedabad-380 009.

Expires on or after
August, 2025

liver
Limited information is available regarding the use of Mergin 0.125mg Tablet in individuals with liver disease. It is essential to consult your doctor before using this medication. Please seek guidance from a healthcare professional to ensure safe and appropriate usage in case of liver issues.

kidney
Limited information is available on using Mergin 0.125mg Tablet in patients with kidney disease. It is recommended to consult a doctor before taking this medication in such cases.

alcohol
Consult your doctor when consuming alcohol with Mergin 0.125mg Tablet.

driving
It is unclear if Mergin 0.125mg Tablet affects driving ability. Avoid driving if you have symptoms that impact focus and reaction time.

pregnancy
Mergin 0.125mg Tablet should be avoided during pregnancy due to known risks to the developing baby. Consult your doctor for safer alternatives. Studies have shown harmful effects on pregnant women and animals.

breastfeeding
During breastfeeding, use Mergin 0.125mg Tablet cautiously. It's advised to pause breastfeeding until the mother's treatment is done and the drug is cleared from her body.
Habit Forming | No |
Chemical Class | Ergolines |
Therapeutic Class | - |
Action Class | Uterotonic and abortificient |
₹81.68
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024